China SXT Pharmaceuticals Files Prospectus Supplement

Ticker: SXTC · Form: 424B5 · Filed: Apr 9, 2026 · CIK: 0001723980

China Sxt Pharmaceuticals, Inc. 424B5 Filing Summary
FieldDetail
CompanyChina Sxt Pharmaceuticals, Inc. (SXTC)
Form Type424B5
Filed DateApr 9, 2026
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: prospectus-supplement, filing, pharmaceuticals

TL;DR

China SXT Pharma filed a 424B5 prospectus supplement on 4/9/26. Watch for potential stock activity.

AI Summary

China SXT Pharmaceuticals, Inc. filed a 424B5 form on April 9, 2026, related to a prospectus supplement. The filing details their business operations and corporate information, including their mailing and business addresses in Taizhou, China, and their CIK number 0001723980.

Why It Matters

This filing indicates a potential offering or update to existing securities, which could impact the company's capital structure and future operations.

Risk Assessment

Risk Level: medium — Prospectus supplements often precede stock offerings or significant corporate actions that can introduce volatility.

Key Numbers

  • 0001723980 — CIK Number (Unique identifier for China SXT Pharmaceuticals, Inc.)
  • 2026-04-09 — Filing Date (Date the 424B5 form was accepted by the SEC.)

Key Players & Entities

  • China SXT Pharmaceuticals, Inc. (company) — Filer of the 424B5 form
  • 0001723980 (company) — CIK number for China SXT Pharmaceuticals, Inc.
  • 2026-04-09 (date) — Filing date of the 424B5 form
  • Taizhou, China (location) — Location of the company's mailing and business addresses

FAQ

What is the purpose of a 424B5 filing?

A 424B5 filing is a prospectus supplement used to provide additional information or updates to an already filed registration statement, often related to the offering of securities.

When was this specific 424B5 filing made by China SXT Pharmaceuticals, Inc.?

The filing date was April 9, 2026.

What is the CIK number for China SXT Pharmaceuticals, Inc.?

The CIK number for China SXT Pharmaceuticals, Inc. is 0001723980.

Where are China SXT Pharmaceuticals, Inc.'s business and mailing addresses located?

Both the mailing and business addresses are located at 178 Taidong Road North, Taizhou, China.

What is the SIC code for China SXT Pharmaceuticals, Inc.?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 424B5 (Form 424B5) was filed with the SEC on April 9, 2026 regarding China SXT Pharmaceuticals, Inc. (SXTC).

View full filing on EDGAR

View Full Filing

View this 424B5 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.